(marketscreener.com) NEW YORK, Feb. 15, 2022 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of BioDelivery Sciences International, Inc. , in connection with the proposed acquisition of the Company by Collegium Pharmaceutical, Inc. via a tender offer. Under the...https://www.marketscreener.com/quote/stock/COLLEGIUM-PHARMACEUTICAL-22148971/news/SHAREHOLDER-ALERT-WeissLaw-LLP-Investigates-BioDelivery-Sciences-International-Inc-39480863/?utm_medium=RSS&utm_content=20220215
BDSI is a North Carolina-based pharmaceutical company that develops and commercializes novel therapies for the treatment of debilitating chronic conditions.